# ANI PHARMACEUTICALS INC (ANIP)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/ANIP/

- Reporting holders: 6
- Reported value: $1.7M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Artemis Investment Management LLP](https://holderbook.com/funds/1535385-artemis-investment-management-llp/) | $1.5M | 20,382 | 0.0% | 4 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $129.5K | 1,783 | 0.0% | 12 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $31.0K | 427 | 0.0% | 20 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $9.8K | 135 | 0.0% | 7 |
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $8.1K | 111 | 0.0% | 7 |
| [GILPIN WEALTH MANAGEMENT, LLC](https://holderbook.com/funds/2058144-gilpin-wealth-management-llc/) | $146 | 2 | 0.0% | 4 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 6 | $1.7M |
| Q2 2026 | 309 | $2.0B |
| Q1 2026 | 278 | $1.9B |
| Q4 2025 | 286 | $1.7B |
| Q3 2025 | 269 | $1.9B |
| Q2 2025 | 231 | $1.3B |
| Q1 2025 | 230 | $1.4B |
| Q4 2024 | 206 | $1.1B |
| Q3 2024 | 208 | $1.2B |
| Q2 2024 | 202 | $980.5M |
| Q1 2024 | 201 | $1.1B |
| Q4 2023 | 181 | $778.3M |